SPOTLIGHT -
No difference was found between treated and untreated eyes
PAUL implant: Good IOP lowering, fewer complications compared with Baerveldt device
Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
Treating anisometropic amblyopia with a dichoptic digital platform
The investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents
Industry-sponsored satellite symposia at the 23rd EURETINA Congress
Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world
